Using a CGM With Type 2 Diabetes

A continuous glucose monitor (CGM) tracks glucose throughout the day and night from a small sensor worn on the body. Instead of a single number from a fingerstick, it shows the direction glucose is heading, how meals and activity affect it, and how much of the day is spent in range. In type 2 diabetes, that continuous picture is increasingly used to guide everyday choices and conversations with a clinician.

What a CGM actually measures

A CGM measures glucose in the interstitial fluid, the fluid that surrounds cells just beneath the skin, rather than directly in the blood. A thin sensor filament sits under the skin and takes a reading every few minutes, sending values to a reader or smartphone. Because interstitial glucose lags slightly behind blood glucose, the strength of a CGM is not any single point but the trend: the shape of the curve over hours and days. This is a different kind of information from a fingerstick, which captures one moment. For background on how the technology works, see our overview of continuous glucose monitoring. This page is part of the type 2 diabetes hub.

Trends, spikes, and time in range

Because it samples continuously, a CGM surfaces patterns that spot checks miss:

• Post-meal spikes: how far and how fast glucose rises after a particular meal, and how long it takes to come back down.
• Overnight patterns: what glucose does during sleep, when no one is testing.
• Trend arrows: whether glucose is steady, rising, or falling right now, context a single value cannot give.
• Time in range: the share of the day glucose stays within an individual target band, a summary metric explained in our guide to time in range.

Seeing these patterns can make the effect of a specific food, a walk after dinner, or a change in sleep concrete rather than abstract.

Why CGMs are used in type 2 diabetes

CGMs were first widely adopted in type 1 diabetes and insulin-treated type 2 diabetes. More recently they are used more broadly in type 2 diabetes, including for some people who are not on insulin, to reveal how food, physical activity, sleep, and medication timing affect glucose. That feedback loop can support behavior change and give a clinician real-world data to work from. Whether a CGM is appropriate, and for how long, is an individual decision that depends on your situation and is best made with your care team. Our primary-care focused piece on CGM in type 2 diabetes in primary care discusses how this fits into routine visits, and managing type 2 diabetes between visits covers the day-to-day side.

Professional versus personal CGM

There are two broad ways a CGM is used:

• Personal CGM: worn on an ongoing basis and owned by the individual, who can usually see readings in real time on a phone or reader.
• Professional CGM: supplied by a clinic for a defined period. The sensor may be "blinded" or visible, and the data is typically reviewed together with a clinician afterward to characterize glucose patterns.

Both approaches aim at the same thing, turning scattered numbers into a pattern that a person and their clinician can act on.

Where decision-support fits

A CGM produces a large amount of data, and interpreting it well is where clinical decision-support has a role. Endobits is decision-support software that helps organize and interpret glucose data, such as trends and time in range, under clinician oversight. It supports the interpretation that informs a care plan; it does not diagnose or treat, and it does not replace a clinician's judgment. The aim is to make the story in the data easier to see so that the person and their care team can have a better-informed conversation.

Sources

American Diabetes Association, Continuous Glucose Monitors (CGM). Centers for Disease Control and Prevention, Monitoring Your Blood Sugar. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Continuous Glucose Monitoring.

Related: The type 2 diabetes guide · Continuous glucose monitoring · Time in range · Managing type 2 between visits · Glossary